Yamakawa, Tadashi <br/><br/>
Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia.  [electronic resource] 

 -  Endocrine journal  2011 
 - 185-91 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1348-4540 
<br/><br/><label>Standard No.: </label>10.1507/endocrj.k10e-255  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Atorvastatin<br/>Blood Glucose--drug effects<br/>Comorbidity<br/>Diabetes Mellitus, Type 2--blood<br/>Epichlorohydrin--pharmacology<br/>Female<br/>Glycated Hemoglobin--drug effects<br/>Heptanoic Acids--pharmacology<br/>Humans<br/>Hypercholesterolemia--blood<br/>Hypoglycemic Agents--pharmacology<br/>Imidazoles--pharmacology<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Pravastatin--pharmacology<br/>Pyrroles--pharmacology<br/>Quinolines--pharmacology<br/>Resins, Synthetic--pharmacology<br/>Retrospective Studies<br/>Treatment Outcome